PICTET & CIE (EUROPE) SA – Apellis Pharmaceuticals, Inc. Transaction History
PICTET & CIE (EUROPE) SA portfolio value:
$498,385
portfolio value
PICTET & CIE (EUROPE) SA quarter portfolio value change:
+51.04%
quarter
Apellis Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 168.38K | $68.3 | 7.29K | |
| Q2 2022 | share | Decrease | -19.54% | -1.77K shares | -131K | $45.22 | 7.29K |
| Q1 2022 | share | Increase | +43.16% | 2.73K shares | 161K | $50.81 | 9.06K |
| Q4 2021 | share | Increase | 0.00% | 6.33K shares | 300K | $47.95 | 6.33K |
| Q3 2021 | share | Decrease | -100.00% | -9.04K shares | -571K | $32.96 | 0 |
| Q2 2021 | share | Increase | +14.72% | 1.16K shares | 233K | $63.2 | 9.04K |
| Q1 2021 | share | Increase | 0.00% | 7.88K shares | 338K | $42.91 | 7.88K |